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Summary: A simple and specific detection method for multiple forms of cystine aminopeptidase (oxytocinase-
isoenzymes) in pregnancy serum is described using S-benzyl-Z,-cysteine-p-nitroanilide as substrate. The relative
distribution of both cystine aminopeptidase isoenzymes at different stages of pregnancy is given.
Eine spezifische Methode zum Nachweis der multiplen Formen von Cystin-Aminopeptidase (Oxytocinase-Iso-
enzyme) nach Polyacrylamidgel-Elektrophorese
Zusammenfassung: Es wird eine einfache und spezifische Methode zum Nachweis der multiplen Formen von
Cystin-Aminopeptidase (Oxytocinase-Isoenzyme) im Serum Schwangerer unter Verwendung von S-Benzyl-Z,-
cystein-p-nitroanilid als Substrat beschrieben. Die relative Verteilung der beiden Cystin-Aminopeptidase-Isoenzyme
in verschiedenen Perioden der Schwangerschaft wird mitgeteilt.
Introduction
The detection methods for oxytocinase-isoenzymes
(cystine aminopeptidase 1 and 2) (EC 3.4.11.3) in
pregnancy serum after polyacrylamide gel electro-
phoresis using jL-leucine-j3-naphthylamide as substrate
are non-specific (1,2, 3). Both cystine aminopeptidase
1 and 2 and leucine aminopeptidase activity (EC 3.4.11.2)
are always detected. Using L-cystme-di-0-näphthylamide
as substrate, only the cystine aminopeptidase isoen-
zymes are demonstrated (4), but both bands on the gel
are too faint for scanning. Moreover, j3-naphthylamides
are carcinogenic.
£-Cystine-bis^nitroanilide and S^benzykZ^cysteine-
p*nitroanilkle are split only by oxytocinase, but in the
assay of oxytocinase the first substrate is less sensitive
than S-benzyl-i-cysteiiie-p-nitroanilide (5). We there-
fore propose a new sjpecific detection method for
cystine aminopeptidase 1 and 2, using a substrate that
does not have these disadvantages: S-benzykC^cysteine-
p-rutrpanilide (6). After electrophoresis the liberated
p-nitroaniline is diazotized during the enzymatic
reaction, then coupled with N-(l-naphthytyethylene-
diamine to yield pink coloured bands (7).
Materials and Methods
The separation of cystine aminopeptidase isoenzymes is based
on the method of I.e. (1).
To achieve good and reproducible separation of both isoenzymes
we have adopted a 75 g/1 acrylamide concentration in the sepa-
ration gel and 0.078 mol/1 borate buffer pH 8.6.
Polyacrylamide gel electrophoresis was carried out with a
Canalco Research Disc Electrophoresis Equipment model 1200
and a Electrophoresis Constant Rate Source model 100 for 1.5 h
at 0° C (5 mA/gel). The detection of the isoenzymes is per-
formed as follows.
Reagents for the detection of cystine aminopeptidase isoenzymes
1. Dissolve 26 mg S-benzyl-L-cysteine-p-nitroanüide (Boehringer
Mannheim or British Drug House) in 20 ml 2-methoxyethanol
(4 mmol/1). Store in a brown bottle at 4°C.
2. Citrate-phosphate buffer pH 6.0. Mix 36.8 ml of 0.1 mol/1
citric acid with 63.2 ml of 0.2 mol/1 Na2HPO4-solution. Store
at49C.
3. Dissolve 50 mg NaNO2 and 10 mg N-(l-naphthyl)-ethylene-
diamine - 2 HC1 (J. T. Baker Chemicals) in 50 ml reagent 2
at 37° C. Prepare before use.
4. Incubation reagent. Add reagent 1 to reagent 3 in a ratio
30 ml + 70 ml
5. Dissolve 125 g trichloroacetic acid in 1 1 water.
Proposed detection-method
After electrophoresis incubate the gels in the incubation reagent
for l h at 37°C Wash the gels l min with water to remove ex-
cess NaNO2 and substrate.
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Incubate the gels l min in reagent 5. Scanning of the gels was
performed with a densitometer Kipp Skalar Densiscan KS 3 filter
530 nm and a XY-Recorder BD 22.
The total serum oxytocinase catalytic concentration was determ-
ined kinetically (5).
Results and Discussion
After incubating the gels in the incubation reagent two
strong pink bands were obtained (Fig. 1). The intensity
of the pink bands became maximal 5—6 min after treat-
ment with trichloroacetic acid and remains constant for
1 h. In sera with low levels of total oxytocinase catalytic
concentration (12-19 U/l) the first isoenzyme to appear,
i. e. cystine aminopeptidase 1, can be easily detected.
In a serum with a total oxytocinase catalytic concentra-
tion of 37 U/l both the cystine aminopeptidase isoenzy-
mes (CAPi and CAP2) can be readily demonstrated
(CAPx 61 % and CAP2 39% of the total activity). In late
pregnancy sera (total oxytocinase catalytic concentra-
tion 115-144 U/l) the activity of cystine aminopeptidase
2 is in general greater than the activity of cystine
aminopeptidase 1: CAPi 37-44% and CAP2 56-63%
of the total activity (Fig. 2).
From the literature (1, 2, 3) it is not clear which iso-
enzyme appears first in the serum during pregnancy.
Kleiner &Brouet-Yager (4) stated that cystine amino-
peptidase 2 is the first isoenzyme to appear. We could not
confirm this. Preliminary results with our detection
method show that cystine aminopeptidase 1 is the
earliest demonstrable isoenzyme.
The relative electrophoretic mobilities of the cystine
aminopeptidase isoenzymes 1 and 2 are: 0.60 ± 0.01
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Fig. 1. Detection of cystine aminopeptidase isoenzymes 1 and 2
(CAPi and CAP2).
1. Our detection method, substrate S-benzyl-£-cysteine-
p-nitroanilide (4 mmol/1).
2. Detection method according to 1. c. (1), substrate
£-leucine-0-naphthylamide (4 mmol/1). Total serum oxy-
tocinase catalytic concentration 116 U/l.
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Fig. 2. Relative distribution of the cystine aminopeptidase iso-
enzymes 1 and 2 (CAPi and CAP2) in sera of different
pregnant women.
1. Total serum oxytocinase catalytic concentration
14 U/l; CAPi 100%, CAP2 0%.
2. Total serum oxytocinase catalytic concentration
37 U/l; CAP! 61 %, CAP2 39%.
3. Total serum oxytocinase catalytic concentration
76 U/l; CAP! 49%, CAP2 51%.
4. Total serum oxytocinase catalytic concentration
144 U/l; CAPi 37%,CAP2 63%.
(Sensitivity in Y-direction is greater than in fig. 1).
and 0.26 ± 0.02 (χ ± SD, N = 10) respectively, using
bromophenol blue as tracking dye.
In contrast with Tovey et al (8) we could not observe
any influence on the intensity of the CAP^ and CAP2
bands, when varying the 2-methoxyethanol concen-
tration from 100 to 300 ml/1 in the incubation-reagent.
We used a 300 ml/12-methoxyethanol concentration,
because of the solubility of S-benzyl-i-cysteine-p-
nitroanilide. The concentrations of NaNO2 and N-
(l-naphthyl)-ethylenediamine given by (7) were too
high, resulting in a turbid incubation reagent. We de-
creased these concentrations to give final concentra-
tions of 10 mmol/1 and 0.5 mmol/1 for NaN02 and
N-(l-naphthyl)-ethylene-diamine respectively, which
gave a clear incubation reagent when dissolved at
37°C.
Further studies on the relative distibution of the
cystine aminopeptidase isoenzymes in normal and
high risk pregnancy sera are in progress,
Acknowledgement
We thank Miss A R. Verhoef for her skillful technical assistance.
J. Ciin. Chem. Clin. Biochem. / Vol. 16,1978 / No. 3
van Buul and van Oudheusden: Specific detection method for cystine aminopeptidase after electrophoresis 189
References
1. Kleiner, H. & Schräm, E. (1966), Clin. Chim. Acta 14, 5. Van Buul, T. & van Oudheusden, A. P. M. (1974), Clin.
377-385. Chim. Acta 54, 263-268.
2. Oya, M., Yoshino, M. & Asano, M. (1974), Experientia 30, 6. Van Oudheusden, A. P. M. (1972), J. Clin. Chem. Clin.
985-986. Biochem. 10, 345-346.
3. Mizutani, S., Yoshino, M. & Oya, M. (1976), Clin. Biochem. 7. Dahlmann, B. & Jany, K. D. (1975), J. Chromatogr. 10,
9,16-18. 174-177.
4. Kleiner, H. & Brouet-Yager, M. (1972), Clin. Chim. Acta 8. Tovey, J. E., Dawson, P. J. G. & FeUowes, K. P. (1973),
40,177-180. Clin. Chem. 19, 756-761.
Dr. T. van Buul
Department of Clinical Chemistry
Sint Jozef Ziekenhuis
NL-7000 AD Doetinchem
The Netherlands
J. Clin. Chem. Clin. Biochem. / Vol. 16, 1978 / No. 3

